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Identifying ZIKV factors interfering with human host pathways represents a major challenge in understanding ZIKV tropism and
pathogenesis. The integration of proteomic, gene expression and Protein-Protein Interactions (PPIs) established between ZIKV
and human host proteins predicted by the OralInt algorithm identified 1898 interactions with medium or high score (≥0.7). Targets
implicated in vesicular traffic and docking were identified. New receptors involved in endocytosis pathways as ZIKV entry targets,
using both clathrin-dependent (17 receptors) and independent (10 receptors) pathways, are described. New targets used by the
ZIKV to undermine the host’s antiviral immune response are proposed based on predicted interactions established between the
virus and host cell receptors and/or proteins with an effector or signaling role in the immune response such as IFN receptors
and TLR. Complement and cytokines are proposed as extracellular potential interacting partners of the secreted form of NS1 ZIKV
protein. Altogether, in this article, 18 new human targets for structural and nonstructural ZIKV proteins are proposed.These results
are of great relevance for the understanding of viral pathogenesis and consequently the development of preventive (vaccines) and
therapeutic targets for ZIKV infection management.
1. Introduction
The Flaviviridae family, Flavivirus genus, consists of a variety
of viruses transmitted by blood-feeding arthropod species,
several of which represent emergent or reemergent pathogens
includingZika (ZIKV),Dengue (DENV),Yellow Fever (YFV),
Japanese Encephalitis (JEV), and West Nile (WNV) viruses.
ZIKV, a previously neglected member of the genus, has
recently been the subject of concern and research since it
has been linked to congenital developmental deficits and
neurological syndromes [1–8].
Flavivirus virions are composed of a single positive-
strand RNA genome, packaged by the viral capsid protein (C)
in a host-derived lipid bilayer and surrounded by 180 copies
of two structural proteins, envelope (E) and membrane (M)
[9, 10]. The genome is translated into a single polyprotein
and subsequently cleaved by viral and host proteases into
three structural proteins (C, prM/M, and E) and seven
nonstructural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A,
NS4B, and NS5) [9, 11].
A successful innate immune response by the host depends
on the efficient detection of the invading pathogen. Flavivirus
use their structural glycoproteins to attach to the host cell,
interacting with several receptors, which trigger endocytosis
pathways. One of the proteins important in this process is
structural E proteinwith plays a role in receptor binding, viral
entry, and membrane fusion, whereas prM assists in folding,
assembly, and function of the E protein [9, 11].The ZIKV uses
the envelope (E) glycoprotein for entry into specific cell types
such as epidermal keratinocytes, fibroblasts, immature den-
dritic cells, and stem-cell-derived human neural progenitors
[12]. Sequence comparisons of the E glycoprotein of ZIKV
with the other members of the Flaviviridae family indicate an
unusual degree of variability including glycosylation within
the ZIKV strains [12]. These differences in glycosylation may
determine a characteristic affinity for human target proteins.
Hindawi
BioMed Research International
Volume 2017, Article ID 1734151, 15 pages
https://doi.org/10.1155/2017/1734151
2 BioMed Research International
Three major attachment factors for Flavivirus are hep-
arin sulfates, dendritic cell-specific ICAM-3-grabbing non-
integrin 1 (DC-SIGN, CD209 antigen), and DC-SIGNR
(CLEC4M), which interact with N-linked glycans of the viral
E glycoprotein. DC-SIGN itself does not provide an essential
internalization signal during DENV entry, suggesting that
additional entry factors exist. It seems that ZIKVmay also use
GAGs (glycosaminoglycans) as attachment factors to enter
the host cell [13].
Another molecule identified as an entry factor for DENV
is AXL [14] which belongs to the TYRO3 AXL MER (TAM)
family, a group of tyrosine kinase receptors involved in the
clearance of apoptotic cells and regulation of innate immunity
[15, 16]. However, for ZIKV, some studies confirm that AXL
is not the key receptor for the viral infection of human neural
progenitor cells [12, 17–20].
Receptor-mediated endocytosis is a prerequisite for
fusion and uncoating of all known Flaviviridae family mem-
bers. Clathrin-dependent uptake has been described as the
major endocytosis mechanism, but alternative entry routes
exist and may be used in a strain-specific manner [21].
After endocytic uptake and acidification of the endo-
somal lumen, the viral surface glycoproteins undergo a
conformational change and induce fusion of the limiting
endosomalmembrane and the viral envelope. Disassembly of
the viral capsid (“uncoating”) delivers the RNAgenome to the
cytoplasm, which completes the entry process [21].
After release of the genome into the cytoplasm, ZIKV
replicates through a negative strand intermediate [9, 12]. For
the nonstructural proteins synthesis and posttranslational
modifications Flavivirus use the virus-induced membranous
vesicles derived from the endoplasmic reticulum and Golgi
complex by exploiting membrane trafficking [22].
Belowwe describe the current evidence of the “hijacking”
of each of the nonstructural proteins with the host cell.
Upon synthesis, the Flavivirus nonstructural proteins may
play different functions within human host cells or may
follow host exocytosis pathways and act outside the host
cell. That is the case of the nonstructural protein NS1, a
46–55KDa glycoprotein containing 2-3 glycosylation sites
[23, 24]. After polyprotein processing, NS1 is translocated
into the lumen of the ER and released from E protein by ER
resident signal peptidase [23, 25]. The C-terminus is cleaved
by an unidentified ER host protease [26] and glycosylated
by the addition of high-mannose carbohydrates [27]. After
a rapid dimerization, NS1 acquires a partially hydrophobic
behaviour and can associate with cell membranes [11, 12, 28,
29]. NS1 protein can associate with the membrane through
a glycosylphosphatidylinositol (GPI) anchor [30]. NS1 has
also been described as being secreted to the extracellular
environment [11, 28, 29]. The secreted form of NS1 traffics
through the Golgi secretory pathway in mammalian cells,
and the carbohydrate moieties are processed to more com-
plex sugars that are then secreted as a soluble hexamer of
∼300 kDa associated with lipids [11, 31–33].
NS2A is a multifunctional protein with roles in virion
assembly [34, 35], RNA replication [36, 37], membrane
permeation [38], and dissemination from infected mosquito
midguts [8, 39, 40]. NS2A has also been shown to act as an
interferon antagonist in different Flavivirus [8, 41, 42]. The
NS2B protein interacts with NS3 to form a stable complex
which functions as a serine protease [43] which has been
shown to interfere with IFN-I induction [44]. ZIKV’s NS3
protein contains a protease and a helicase domain that in
several Flavivirus act independently of each other [45].
NS4B is an important IFN-I signaling antagonist during
DENV2 infections by inhibiting the JAK/STAT pathway and
antagonising STAT1 phosphorylation [46]. Unlike DENV,
YFVNS4B blocks RIG-I through an interaction with STING.
This highlights strain-specific variations used for IFN sup-
pression between different Flavivirus [8].
NS5 offers some protection for the virus by producing
capped viral RNA, enabling host RNA mimicry through
its methyltransferase activity [47–50]. NS5 displays two
enzymatic activities via the N-terminal methyltransferase
domain and the C-terminal RNA dependent RNA poly-
merase (RdRp), which replicates viral RNA [51, 52].
Despite the description of receptors, entry factors or
pathways for Flavivirus action, based on several experimental
approaches, the specific cell surface receptor and endocytosis
complexes, fusionmechanisms, and entry pathways for ZIKV,
are not yet clear.
Although there is a similar genomic organization between
ZIKV and DENV, nonstructural proteins exhibit low homol-
ogy [53]. The recent publication of the spatial organization
of the ZIKV proteins during the intracellular passage of the
virus [54] and the high recombination frequencies seen in it
suggest that ZIKV has potentially evolved faster and attained
the ability to exploit multiple cell surface receptors and
cellular factors to facilitate infection in a variety of cells types,
differing from other Flavivirus.These evidences prompted an
investigation of new ZIKV targets as a result of ZIKV specific
PPIs established with the human host cell. Our approach was
to use a computational-based analysis which is faster and
more cost-effective than experimental methods and may be
valuable for generating preliminary models.
This article presents information on potential Protein-
Protein Interactions (PPIs) established between ZIKV struc-
tural and nonstructural proteins and human host proteins
predicted by the OralInt algorithm [55]. The predicted PPIs
are discussed considering the different mechanisms that have
been proposed for Flavivirus and the intracellular localization
of the viral proteins during the infection cycle.
2. Materials and Methods
This article aims at the clarification of themolecular entry and
dissemination mechanisms of Zika virus by using a machine
learning model for predicting the interactions established
between the virus and the host proteins (PPI). These pre-
dictions are subsequently explored by a functional analysis
based on the collection, organization, and interpretation of
published information.
2.1. Human-Zika Virus Interactome Prediction. The predic-
tion of the PPIs established between Zika virus and human
proteins was performed using the OralInt tool developed by
our group [55] which allows the prediction of interspecies
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PPIs. The input data were the human reviewed proteome
(Proteome ID:UP000005640) (20199 proteins) and the ZIKV
polyprotein sequence (Uniprot: Q32ZE1) using each of the
processed proteins, both deposited in UniProt [65] as of
January 2017. Of the 14 ZIKV proteins listed in UniProt, only
the 10, which are currently considered functionally impor-
tant, were used. Throughout this document, the proteins are
identified by either their UniprotKB AC, gene, or protein
name depending on the analysis performed.
The predicted interactions were stratified and analyzed
according to the prediction score (0.9–1.0: very high con-
fidence; 0.7–0.9: high confidence; 0.4–0.7: medium con-
fidence; 0.1–0.4: low confidence). Interactions with scores
lower than 0.1 were discarded. An Excel file with predicted
PPIs used in this article is provided as supplementary mate-
rial.
2.2. Visualization of PPI Network between Human and Zika
Virus. A network of the predicted very high confidence
PPIs (score ≥ 0.9) was generated using Cytoscape 3.5.0
[59]. To facilitate data interpretation, a network analysis was
performed using theNetworkAnalyzer Tool fromCytoscape,
and visualizationwas obtained bymapping the node size onto
degree (number of PPIs for each node) and the edge size
onto score. An interactive network diagram created with the
latest version of Cytoscape is included in the supplementary
material.
2.3. Data of Protein Expression after Zika Virus Infection. To
complement the functional analysis of the proteins involved
in viral entry and virulence, data on the quantification of
different proteins upon viral infection were used. As of
March 2017, there were 2 studies with a large scale protein
quantification in 2 different types of cell: (1) infected primary
human fibroblasts [17] and (2) human cortical neural pro-
genitors cells (hNPCs) [56]. In Hamel et al. 2015, the values
represent fold inductions of mRNA copy numbers in infected
cells relative to mock-infected cells and fold change values
after 6 and 24 h are presented [17]. For hNPCs, fold change
values were calculated from the log 2 values presented in the
article using the inverse function 𝑦 = 2∧𝑥 to ensure data
standardization; this enables the comparison of the values
obtained in the two studies. To facilitate interpretation, fold
changes intervals were normalized by recalculating values
between 0 and 1 as -(1/fold change). Protein quantification
data used for discussion of results is available as an Excel file
in the supplementary material.
2.4. Analysis of PPIs by Functional Role in Zika Virus Infection.
For the study of the molecular mechanisms potentially
involved in viral entry into the host, and subsequently intra-
cellular affected mechanisms, an analysis of the predicted
PPIs between the viral proteins and the host endocytosis
receptors, immune response, and cytosolic host response pro-
teins was performed. For this analysis, only the interactions
with a score ≥ 0.2 were considered.
To verify which human proteins identified as having the
potential to interact with the viral envelope and membrane
proteins (score ≥ 0.2) have been described as membrane
receptors involved in viral entry into the host cell, two
approaches were followed:
(1) KEGG’s [60, 61] mapping tool was used to identify
proteins related to endocytosis.
(2) A review of the receptors involved in macropinocyto-
sis of Flaviviridae [62] was used.
To evaluate how ZIKV modulates the host immune
response, the PPIs established between the different ZIKV
proteins and the host receptors and other proteins that have
an effector or a signaling role in the immune response were
analyzed. These data were integrated with data from expres-
sion fold change available for skin and hNPCs obtained as
explained in Section 2.3 of the Material and Methods.
The initial sensing of infection is mediated by innate
pattern recognition receptors (PRRs), which include Toll-
like, RIG-I-like, NOD-like, and C-type lectin receptors. The
intracellular signaling cascades triggered by these PRRs lead
to transcriptional expression of inflammatory mediators that
coordinate the elimination of pathogens and infected cells. To
identify the molecular mechanisms used by ZIKV to bypass
this defense system, PPIs predicted by OralInt between
human and viral nonstructural proteins were considered.
VirHostNet 2.0 [63] complemented with the information
present in ViralZone [64] were used to identify PRRs already
described as being involved in ssRNA viruses recognition.
2.5. Zika and Dengue Virus Protein Homology Determination.
The homology between the nonstructural ZIKV (strain Mr
766) and DENV (Dengue virus type 1 (strain Nauru/West
Pac/1974) (DENV-1)) proteins was determined by using the
ClustalOmega [66] algorithmprovided as anAlignment Tool
in UniProt [65].
3. Results and Discussion
3.1. Human-Zika Virus Predicted Interactome. Using OralInt
[55], human-ZIKV interactome was determined and a sum-
mary of the results is presented in Table 1.The predicted PPIs
are complemented with the annotation of the proteins which
have been quantified in different human cells upon ZIKV
infection. The quantification data pertain to transcriptomics
data on the human proteins expressed by skin [17] and
hNPCs cells [56] upon ZIKV infection. From a total of
1898 high to medium score (0.7–1) predicted PPIs, there are
transcriptomics data on 726 of the human proteins involved.
From these, the PPIs established between human and E and
M ZIKV structural proteins are especially relevant for the
identification of human target receptors.
Up to now, there is only one study that experimentally
validates PPIs related to ZIKV infection [67]. OralInt predicts
all of the 143 experimentally described interactions between
NS2A and the human proteins and 33 of those are predicted
with high or medium confidence.
Table 2 presents the number of human proteins interact-
ing with a specific ZIKV protein, for which the PPIs have a
score ≥0.4 and the annotation of the up- or downregulation
of the human protein according to the values obtained in
previous experiments reported in the literature [17, 56]. Since
there has been interest in the identification and quantification
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Table 1: Number of interactions between human and ZIKV proteins predicted by OralInt according the score (0.9–1: very high confidence;
0.7–0.9: high confidence; 0.7–0.4: medium confidence). Quantification refers to the number of human proteins which have been identified
as being expressed upon ZIKV infection of fibroblast (skin) and human cortical neuronal progenitor cells (hNPCs).
Zika protein OralInt score 0.9–1 OralInt score 0.7–0.9 OralInt score 0.4–0.7
PPI Quantified hNPCs∗ PPI Quantified hNPCs∗ + Skin∗∗ PPI Quantified hNPCs∗ + Skin∗∗
Capsid (C) - - 168 64 3236 1055 + 14 (4)
Envelope (E) 7 3 124 42 + 1 2757 838 + 11 (3)
Membrane (M) 1 - 67 15 1314 369 + 3
NS1 3 - 119 39 + 1 2612 824 + 10 (3)
NS2A 2 1 264 81 + 1 4478 1486 + 17 (6)
NS2B 11 7 439 148 + 2 4649 1604 + 18 (4)
NS3 1 1 33 12 + 1 979 304 + 3 (1)
NS4A - - 124 41 + 1 2618 840 + 12 (3)
NS4B 9 - 292 83 + 1 3858 1189 + 12 (4)
NS5 5 2 229 78 + 1 3970 1330 + 17 (5)
Total 39 14 1859 603 + 9 30471 9869 + 103
∗[56]; ∗∗[17].
Table 2: Number of human proteins establishing PPIs exclusively with each ZIKV protein; human proteins expression regulation upon ZIKV
infection (when available) and respective presence in saliva. Only PPIs with scores ≥ 0.4 are shown.
Zika protein Total PPIs Human proteins with expression data
∗
Proteins present in saliva∗∗
Upregulated Downregulated
E 105 16 21 8
M 62 8 9 3
NS1 131 16 14 4
NS2A 638 85 94 22
NS2B 1066 214 175 45
NS3 1 - 1 -
NS4A 46 5 7 3
NS4B 300 37 43 8
NS5 557 90 106 22
∗Quantification in human cortical neural progenitor cells (hNPCs) [56] and skin (fibroblasts) [17]. ∗∗Presence in saliva from OralCard [57, 58].
of salivary biomarkers for this infection, proteins previously
identified in saliva are also annotated [57, 58].
The network of PPIs with a very high confidence score
(≥0.9) is presented in Figure 1. No PPIs with the highest score
were identified for the C and NS4A proteins. The viral pro-
teins establishing the largest number of interactions are NS2B
(protein which forms a complex with NS3 showing serine
protease activity), NS4B, and E (the main protein binding to
membrane receptors). Proteins with available quantification
are also identified.
From the proteins interacting with the multifunctional
ZIKV NS2B protein (Figure 1), the Rho-related BTB domain
containing 3 (RHOBTB3) is of special note, since it is a Rab9-
regulated ATPase required for vesicle transport and docking
at the Golgi complex [68]. The prediction of this PPI with
a high score is evidence that ZIKV interferes with vesicular
organization and host dockingmechanisms. Another protein
establishing high score PPIs and involved in vesicular traffic is
BICD1 (bicaudal D homolog 1 (Drosophila)) which regulates
coat complex coatomer protein I- (COPI-) independent
Golgi-endoplasmic reticulum transport by recruiting the
dynein-dynactin motor complex [68]. Similarly, silencing
and CRISPR/Cas9 knockout screens have previously identi-
fied another GTase Rab (RAB5C) and Rab-activating guano-
sine diphosphate/guanosine triphosphate exchange factors,
GEFs (RABGEF), as vesicular transport factors contributing
to Flavivirus effective invasion of the host cell [21].
3.2. New Endocytosis Pathway Targets Used by Zika Virus.
Considering PPIs with a score ≥ 0.2 established between E
and M ZIKV proteins and human membrane receptors, it
is possible to identify potential entry mechanisms used by
ZIKV.
Table 3 presents the receptors that ZIKV may use in both
clathrin-dependent and independent pathways of endocyto-
sis for infecting human cells. For each human to ZIKV E
and M protein PPI, the respective score is presented. This
information is completed with data from the quantification
available in the literature [17, 56].
Regarding the use of receptors involved in clathrin-
dependent endocytosis by ZIKV, the greater scores are for
PPIs established with the GRPCR and RTK type receptors.
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Table 3:Membrane receptors as potential targets for ZIKV entry into host cells. Only proteins establishing PPIswith scores≥ 0.2 are presented
(OralInt prediction).




ADRB2 P07550 0.4 3.6
ADRB3 P13945 0.3 0.4
ADRB1 P08588 0.2 0.2
CCR5 P51681 0.2
CXCR4 P61073 0.2




FGFR2 P21802 0.2 1.7




TFR TFRC P02786 0.2
TGFBR




Caveolin CAV2 P51636 0.2 0.2
CAV3 P56539 0.2 0.6
Others
CD81 P60033 0.3 0.4 −1.2
CLDN1 O95832 0.3 0.3 2.5
IL2RG P31785 0.3
OCLN Q16625 −1.3
TIM HAVCR2 Q8TDQ0 0.4 0.2
TAM AXL P30530 0.2 1.3
DC-SIGN CD209 Q9NNX6 0.2 0.2
L-SIGN CLEC4M Q9H2X3 0.2 0.2















































Figure 1: Network of OralInt predicted PPIs (score ≥ 0.9) established between ZIKV proteins (blue) and human proteins (orange).The size of
the node denotes the degree (number of interactions established). Red denotes underexpressed and green overexpressed proteins. Expression
data from Tang et al. 2016 [56]. Diagram generated with Cytoscape V3.5.0 [59].
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The interaction of ZIKV E protein with the beta-2 adrenergic
receptor (ADRB2) of the GRPCR family, which mediates
the catecholamine-induced activation of adenylate cyclase
through the action of G proteins, is predicted with a score
of 0.4. The PPI established between the ZIKV M protein
and the ADRB3, a beta-3 adrenergic receptor, also has a 0.4
score.TheRTK receptor type, namely, hepatocyte growth fac-
tor receptor (MET), which during embryonic development
has a role in gastrulation, development, and migration of
muscles and neuronal precursors, angiogenesis, and kidney
formation, establishes with ZIKV E protein a PPI with 0.4
score.
Belonging to the GRPCR type receptors, the CCR5
(chemokine C-C motif receptor 5) and CXCR4 (chemokine
C-X-C motif receptor 4) both establish interactions with
ZIKV E protein having a score of 0.2.
From the RTK type receptors, ERBB4, a tyrosine-protein
kinase that plays an essential role as cell surface receptor
for neuregulins, together with the EGF family members,
regulates development including the central nervous system.
Therefore, they are worthy of special note due to their
potential impact in central nervous system development.
Table 3 identifies 10 receptors for clathrin-independent
endocytosis. AXL receptor which belongs to the TYRO3AXL
MER (TAM) family, a group of tyrosine kinase receptors
involved in the clearance of apoptotic cells and regulation of
innate immunity [15, 16], is the best described target of
Flavivirus. It has been shown that AXL is also the primary
ZIKV entry cofactor on human umbilical vein endothelial
cells (HUVECs) and that ZIKV uses AXL with much greater
efficiency than DENV or WNV, by binding the AXL ligand
GAS6 which recognizes phosphatidylserine (PS) exposed
at the surface of the viral envelope and bridges the viral
particle binding to the AXL receptor.Thismechanism of viral
entry, based on PS exposure, has been termed viral apoptotic
mimicry [62]. From OralInt’s results we can conclude that E
ZIKV protein establishes a PPI with AXL with a 0.2 score,
having the potential of interacting also with GAS6 with a
score of 0.1. With M ZIKV protein, GAS6 establishes a PPI
with a score of 0.2.
Once AXL is activated, it mediates signaling through its
tyrosine kinase domain to dampen type I interferon (IFN1)
signaling and facilitate infection [14, 69, 70]. Since AXL is
expressed on primary humanplacental cells, endothelial cells,
fibroblast cells, amniotic epithelial cells, trophoblast progen-
itors, and macrophages (Hofbauer cells) the maternal-fetal
transmission of ZIKV is facilitated [12, 71–73]. AXL was
recently shown to support ZIKV infection of human foreskin
fibroblasts [17] and its expression was noted in the brain and
neural progenitor cells [74–76].
According to our PPI scores, the TIM type receptor was
the highest for the ZIKV clathrin-independent endocytosis
mechanisms. Within that group of receptors, the hepatitis A
virus cellular receptor 2 (HAVCR2) establishes a PPI with a
0.4 score with ZIKV protein E. However, other receptors also
seem to interact with ZIKV proteins, namely, the caveolin-
3 (CAV3) which establishes a PPI with M protein having a
score of 0.6. Caveolins like CAV2 andCAV3 act as scaffolding
proteins within caveolar membranes that interact directly
with G-protein alpha subunits and can functionally regulate
their activity. Internalization via caveolae is not a constitutive
process but only occurs upon cell stimulation. It has been
described that caveosomes participate in the transport of
the simian virus 40 and other pathogens from the cell
surface to the endoplasmic reticulum [77]. Caveolin-2 is
most prominently expressed in fibrous and adipose tissue and
caveolin-3 is restricted to striated and smooth muscle. We
hypothesize that this may be another pathway through which
maternal-fetal transmission occurs.
The M protein of ZIKV also establishes a PPI with CD81
with a 0.4 score. Both E and M proteins establish PPIs
with claudin-1 (CLDN1) with a score of 0.3 and it has been
shown that the expression of this protein had a 2.5-fold
increase upon ZIKV infection. CLDN1 plays a major role in
tight junction-specific obliteration of the intercellular space
through calcium-independent cell-adhesion activity that reg-
ulates the permeability of epithelia. Claudin-1 and CD81
have also been related to the HCV entry into host cell
[60, 61].
It is known that membrane proteins when interacting
with other proteins (cognate ligands) are subject to confor-
mational changes. We think that the same happens when
the E ZIKV structural protein binds to the host membrane
receptors and causes the exposure of M protein interaction
domains. It has been described that Flavivirus structural
proteins assumemany asymmetric states [78] and are in con-
tinuous dynamic motion [79], which likely exposes patches
of the virion membrane [80]. Both facts would explain why
ZIKV M protein might interact with the host cell receptors
showing a high score, as what happens in the PPIs established
with CAV3 and CD81.
Additionally, Table 3 shows the scores of PPIs estab-
lished between ZIKV and C-type lectins dendritic cell-
specific intercellular adhesion molecule-3-grabbing noninte-
grin (DC-SIGN), a pathogen-recognition receptor expressed
on the surface of immature dendritic cells involved in
initiation of primary immune response that mediates the
endocytosis of pathogens [17], and DC-SIGN-related protein
(L-SIGN). Both E andM ZIKV proteins establish PPIs with a
score 0.2 with DC-SIGN and with the C-type lectin domain
family 4 member M (CLEC4M), a L-SIGN type receptor for
mannose-like carbohydrates [81].
3.3. New Immune Targets Used by Zika Virus. ZIKV modu-
lation of the immune response mechanisms may be seen as
an action controlled by the viral E and M structural proteins
which bind and activate human receptors or interact with
other membrane proteins or even bind extracellular proteins
impairing their action. Once the nonstructural proteins are
produced they may exert their function by binding and/or
modifying the host proteins available. Protein synthesis of
ZIKV proteins follows the endomembrane trafficking system
in a similar fashion as to what happens with the host proteins
up to theGolgi complexwhere glycosylation ends.This whole
pathway has been demonstrated for NS1 and this nonstruc-
tural protein may also be secreted just as the host proteins
and exert its actions in extracellular compartments.
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In Table 4, PPIs established between different ZIKV pro-
teins and host receptors and other proteins with an effector or
a signaling role in the immune response are presented. Addi-
tionally, information relative to the fold change is annotated
for skin and hNPCs when available [17, 56].
IFN and TLRs receptors are important to convey signals
to the cell and initiate antiviral defensemechanisms.Whether
ZIKV is able to bind IFN receptors is still not clear. OralInt
predicts PPIs between ZIKV E protein and IFNAR1/IFNAR2
receptor subunits, with scores 0.3 and 0.2, respectively
(Table 4). After type I IFN binding to IFN receptor, the signal
pathway leads to the induction of an antiviral state [13, 82].
The PPI scores with ZIKV E protein and TLR2 or TLR4
are 0.3. ZIKV E and M proteins can both interact with TLR6
(0.2 score).
It has been demonstrated that nonstructural proteins
of Flavivirus may interact with TLR receptors. In the case
of DENV, it was shown that NS1 (probably the soluble
hexamer) binds TLR4 on the surface of CD14+ monocytes
and induces cellular activation, cytokine production, and
vascular permeability, a similar response triggered by the
bacterial LPS [11]. The results presented in Table 4 show that
all ZIKV proteins, except NS3, establish PPIs with TLRs with
scores ranging from 0.2 to 0.5.
Complement proteins are an important part of the innate
immune response and as signaling molecules for different
types of immune cells.
DENVNS1 can attenuate activation of the classical, lectin,
and alternative pathways by interacting with complement
proteins and their regulators [83].
C8B, a constituent of the membrane attack complex
(MAC) that plays a key role in the innate and adaptive
immune response by forming pores in the plasmamembrane
of target cells, is the protein that establishes PPIs with the
highest scores with ZIKV proteins. M ZIKV protein interacts
with C6 and C8B with scores of 0.7 and 0.6, respectively.
Cytokines and chemokines may interact with structural
and nonstructural ZIKV proteins (Table 4) with scores of
0.2–0.7 for both.
3.4. New Immune Modulation Pathway Targets Used by Zika.
The coevolution between Flavivirus and their hosts has taken
place over a long period. Host cells have developed multiple
branches of innate immune system to keep the virus invasion
and replication under control [84]. Conversely the viruses
have developed different mechanisms to evade the induction
of an antiviral state by the host cell and in some cases the
prevention of the triggering of the apoptotic state of the
host cell. A synergistic effect of nonstructural proteins to
restrict cellular antiviral responses at multiple levels has been
demonstrated [13].
Table 5 presents the predicted PPIs established between
the nonstructural proteins of ZIKV and proteins of the host
pathways leading to an antiviral state (IFNs) and proinflam-
matory cytokine (TNF𝛼) synthesis which are depicted in
Figure 2. The integration of fold change data in skin and
hNPCs in Figure 2 allows the evaluation of the pathways
which may occur in these two cell types during ZIKV
infection.
Several PRRs have been demonstrated as being activated
for different Flavivirus. These include Toll-like receptors
(TLR) mediated responses, specific nucleic acid receptor
activation such as RIG-I and PKR, and the mitochondrial
antiviral immunity (MAV) and IFN receptors dependent
pathways. Figure 2 also integrates the signaling pathways
dependent on endocytosis receptors which were previously
discussed (Table 3).
The detection of cytoplasmic viral RNA [85] is accom-
plished by RLRs as DDX58 (the retinoic acid inducible
gene-1) (RIG-I), a RNA helicase that recognizes viral RNA
present within the cytoplasm and melanoma differentiation-
associated protein 5 (MDA5) [86].
RIG-I recognizes short RNA ligands with 5󸀠-triphosphate
caps. MDA5 recognizes long kilobase-scale genomic RNA
and replication intermediates. Ligand binding induces con-
formational changes and oligomerization of RLRs that acti-
vate the signaling partner MAVS on the mitochondrial and
peroxisomalmembranes.This signaling process is under tight
regulation, dependent on posttranslational modifications of
RIG-I and MDA5. Both contain a helicase domain and a
C-terminal domain, which are involved in the binding of
viral RNA. This then signals through IRF3/7 activating the
transcription of IFNs [87].
The RIG-I molecule is upregulated with a fold change
of 4.9 after 24 hours of infection of fibroblasts and of the
TRIM25 an E3 ubiquitin ligase, which further activates RIG-I
(Table 5). TRIM25 functions as an E3 ligase, which adds poly-
ubiquitin chains to the amino-terminal of RIG-I [87]. This is
thought to facilitate the interaction of RIG-I withMAVS, thus
modulating downstream signaling of the IFN-I response.
RIG-I has been demonstrated as modulating DENV
antiviral response [88]. Through the direct interaction and
modulation of I𝜅B kinase 𝜀, an important kinase involved
in IFN-I induction, DENV NS2B/NS3 disrupts RIG-I, the
signaling pathway.
ZIKV nonstructural proteins establish PPIs with scores of
0.2 with RIG-I, whereas PPIs established with TRIM25 and
MDA5 have scores between 0.3 and 0.6. The RNA sensing
mechanism MDA5, also known as interferon induced with
helicase C domain 1 [88] upon ZIKV infection of fibroblasts,
has a similar variation to RIG-I, decreasing initially and being
upregulated with a fold change of 7.3 after 24 hours (Table 5).
This evidence points to a delayed cell response, which seems
to be dependent on the presence of several ssRNA molecules
which only happens after the virus initiated replicationwithin
the host cell.
Recently, it has been shown that when ZIKV infects
the primary human placental macrophages and placental
cytotrophoblasts, it induces the production of IFN-𝛼, proin-
flammatory cytokines, and antiviral genes such as RIG-I
and MDA5 [89]. Also during infection, ZIKV stimulates cell
death and induces type I interferon (IFN) response and
proinflammatory cytokines that disrupt the placental barrier
leading to neurological disorders such as microcephaly [74].
The IFNs bind to a heterodimeric transmembrane recep-
tor which results in the recruitment and activation of tyrosine
kinases, JAK1 and TYK2, through auto- and transphospho-
rylation. This process drives the recruitment and subsequent
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Figure 2: Diagram representing membrane and cytosolic targets of ZIKV used for host cell entry and immune response modulation.
Information was obtained from OralInt predicted PPIs and the literature [60–64].
phosphorylation of the cytoplasmic transcription factors,
STAT1 and STAT2, which translocate to the nucleus and
associate with IRF9 to activate IFN genes.
NS5 has been described as a potent Flavivirus IFN-I an-
tagonist [90] by STAT1/2 activation or translocation. DENV
NS5 binds and degrades STAT2 by targeting it for ubiquitin-
mediated proteasomal degradation [91].
NS2B and NS4B from ZIKV establish PPIs with a 0.4
score with JAK1 and a score of 0.3 with TYK2. Both tyrosine
kinases, JAK1 and TYK2, are upregulated in hNPCs under
ZIKV infection (Table 5). All the nonstructural ZIKV pro-
teins establish PPIs with STAT1 (scores 0.5–0.8). Similarly,
experimental studies have confirmed that ZIKV NS5 is
required for the proteasomal degradation of the STAT2 in
humans [92, 93]. However, OralInt’s score for STAT2 PPIs
established with viral proteins is only 0.3. We propose that
STAT1 may be a potential ZIKV target.
During Flavivirus infections TLR7, TLR8, TLR9, and the
dimerization complex TLR7 with TLR9, which identify RNA,
are important factors for virus detection. All TLRsmentioned
signal through an intermediate protein, MYD88, which
eventually leads to activation of the nuclear factor kappa-B
(NFKB), a pleiotropic transcription factor present in almost
all cell types. One of the cytokines which results from the
activation of this pathway, TNF-alpha, is downregulated
(Table 5) which indicates that, despite being noticed by the
cell, the virus somehow inhibits, at least temporarily, a
systemic inflammatory response by avoiding the release of
proinflammatory cytokines.
NS1 and NS2A ZIKV proteins can interact with MYD88
(0.4 score). NS4B establishes a PPI with a score of 0.3 with
MYD88. Both NS2B and NS5 interact with MYD88 with a
score of 0.4. Curiously, NS2B, the serine protease of ZIKV,
can interact with NFKB with a score of 0.4 and may result in
the degradation of the transcription factor by the activity of
the viral protease.
It was recently demonstrated that IFN𝛽 restricts repli-
cation of ZIKV and promotes autophagic degradation of
NS2B/NS3 complex, which explains the host innate immune
protective defense against ZIKV. As the ubiquitination of
NS2B/NS3 is enhanced by IFN𝛽 treatment and STAT1 is
required for the degradation of NS2/NS3, the potential IFN-
inducible E3 ligases might be involved in this process. Many
E3 ligases such as tripartite motif (TRIM) proteins family
members, including TRIM25, can be upregulated by IFN
through STAT1 [94].














































Figure 3: Summary diagram of the proposed ZIKV targets considering the intra- and extracellular localization of the viral proteins during
the infection cycle. Scores of the OralInt predicted PPIs are presented next to each human protein target and refer to interaction with the
specific ZIKV protein. The proposed membrane orientation of the ZIKV proteins was modified from Figure 25.4 in Shi and Gao (2017) [54].
The PPIs predicted by OralInt show high scores for
interaction of TRIM25 (NS2B—0.4). The PPI score between
IFN𝛽 and NS2B is 0.2 and with NS3 is 0.3.
The fact that there is a low homology between the non-
structural DENV and ZIKV proteins, as determined by the
UniProt Alignment Tool [65], especially forNS1 (54%), NS2A
(24%), NS2B (37%), NS3 (65%), and NS5 (65%), further
supports the search for different targets and the establishment
of different PPIs than those described for DENV.
Although ZIKV uses many of the main pathways ex-
ploited by other Flavivirus to infect human cells, which is
represented in the PPIs predicted by OralInt, new ZIKV
targets are possible within the same general pathways based
on higher score of the PPIs obtained.
4. Conclusion
Theanalysis of the ZIKV-human interactome reveals that this
virus shares some of the targets and strategies with other
Flavivirus to infect human host cells. However, we found new
interactions that support the existence of different human
protein targets which may be used specifically by ZIKV
to invade and disrupt the host cell homeostasis (Figure 3).
Despite having a similar genome organization as other
Flavivirus, the low homology between ZIKV and DENV
nonstructural proteins justifies the analysis and in silico
search for new targets and we believe that these are worthy
of further attention. The computational approach for the
discovery of new targets and mechanisms of ZIKV-human
infection is an expedite and efficient way of making new
proposals which should be experimentally confirmed by
quantitative proteomics analysis enabling the development of
innovative preventive (vaccines) or therapeutic approaches.
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